Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients (Q42676804)

4 November 2017

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients (English)

1 reference

4 November 2017

1 reference

Boehm BO

1

1 reference

4 November 2017

Home PD

2

1 reference

4 November 2017

Behrend C

3

1 reference

4 November 2017

Kamp NM

4

1 reference

4 November 2017

Lindholm A

5

1 reference

4 November 2017

1 May 2002

1 reference

4 November 2017

1 reference

4 November 2017

19

1 reference

4 November 2017

5

1 reference

4 November 2017

393-399

1 reference

Insulin analogs with improved pharmacokinetic profiles

4 November 2017

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Monomeric insulins and their experimental and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Design of insulin analogues for meal-related therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

The effects of improved glycemic control on complications in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

The postprandial state and the risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Injection-meal interval: recommendations of diabetologists and how patients handle it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Are presently available insulin analogues clinically beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Roles of site and timing of the morning insulin injection in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

Monomeric insulins obtained by protein engineering and their medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00733.X

10.1046/J.1464-5491.2002.00733.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference